← FDA Drug Approvals (Drugs@FDA)
DOLUTEGRAVIR
NDA · New Drug Application · Sponsor: LAURUS GENERICS INC · Approved 2023-04-28
Drug application
- FDA Application #
NDA215319- Application type
- New Drug Application
- Brand name
- DOLUTEGRAVIR
- Generic name
- Dolutegravir
- Active ingredients
- DOLUTEGRAVIR
- Dosage form
- FILM
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- LAURUS GENERICS INC
- First approval
- 2023-04-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown